Anti-Inflammatory Panacea? The Expanding Therapeutics of Interleukin-1 Blockade

Current Opinion in Rheumatology - United States
doi 10.1097/bor.0000000000000266
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Anti-Inflammatory Properties of a Novel Peptide Interleukin 1 Receptor Antagonist

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Anti-Caveolin-1 Antibodies as Anti-Prostate Cancer Therapeutics

Hybridoma
2012English

Anti-Inflammatory Effects of Interleukin-19 in Vascular Disease

International Journal of Inflammation
AllergyImmunology
2012English

Anti-Inflammatory Mechanisms of the Novel Cytokine Interleukin-38 in Allergic Asthma

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2019English

P087 the Anti-Inflammatory Cytokine Interleukin 37 Is an Endogenous Inhibitor of Trained Immunity

2019English

Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-Cd20 Therapy

JAMA Neurology
Neurology
2013English

Involvement of Interleukin-1 in the Inflammatory Actions of Aminobisphosphonates in Mice

British Journal of Pharmacology
Pharmacology
2000English

471 Interleukin 1 Alpha Activates the Skin Injury-Induced Inflammatory Response

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

An Interleukin-1 Signature in Breast Cancer Treated With Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy